<--- Back to Details
First PageDocument Content
Hypertension / Vitamin D / Blood pressure / Antihypertensive drug / ACE inhibitor / Cardiovascular disease / Hypovitaminosis D / Angiotensin II receptor antagonist / Heart failure / Health / Medicine / Nutrition
Date: 2013-04-27 22:31:49
Hypertension
Vitamin D
Blood pressure
Antihypertensive drug
ACE inhibitor
Cardiovascular disease
Hypovitaminosis D
Angiotensin II receptor antagonist
Heart failure
Health
Medicine
Nutrition

Microsoft Word - GPupdate14.doc

Add to Reading List

Source URL: www.hbprca.com.au

Download Document from Source Website

File Size: 33,81 KB

Share Document on Facebook

Similar Documents

PRODUCT MONOGRAPH  COZAAR® losartan potassium tablets 25, 50 and 100 mg Angiotensin II Receptor Antagonist

PRODUCT MONOGRAPH COZAAR® losartan potassium tablets 25, 50 and 100 mg Angiotensin II Receptor Antagonist

DocID: 1uB2r - View Document

Comments to the 2007 recommendations for the treatment of essential hypertension by the Swiss Society of Hypertension

Comments to the 2007 recommendations for the treatment of essential hypertension by the Swiss Society of Hypertension

DocID: 1r7aU - View Document

lisinopril pregnancy class. lisinopril dosis letal, lisinopril vs altace hydrochloroth lisinopril. negative side effects of lisinopril. lisinopril zinc and selenium lisinopril tablets wockhardt, dangerous side affects of

lisinopril pregnancy class. lisinopril dosis letal, lisinopril vs altace hydrochloroth lisinopril. negative side effects of lisinopril. lisinopril zinc and selenium lisinopril tablets wockhardt, dangerous side affects of

DocID: 1qMap - View Document

6213 Old Keene Mill Court ♦ Springfield, VAPhone:  ♦ www.PQAalliance.org ♦ Fax: CONTACT: Woody Eisenberg Sr. VP, Performance Measurement & Strategic Alliances

6213 Old Keene Mill Court ♦ Springfield, VAPhone: ♦ www.PQAalliance.org ♦ Fax: CONTACT: Woody Eisenberg Sr. VP, Performance Measurement & Strategic Alliances

DocID: 1qilE - View Document

GuidelinesGuidelines

GuidelinesGuidelines

DocID: 1oUt8 - View Document